Does remdesivir have any neuropsychiatric adverse effects?
Sign Up to like & getrecommendations! Published in 2020 at "Irish Journal of Psychological Medicine"
DOI: 10.1017/ipm.2020.67
Abstract: On 1 May 2020, the US Food and Drug Administration issued an emergency use authorisation for remdesivir in the treatment of hospitalised COVID-19 patients (Food and Drug Administration, 2020). Remdesivir is a nucleotide analogue antiviral… read more here.
Keywords: effects remdesivir; drug; adverse effects; neuropsychiatric adverse ... See more keywords